Canada markets open in 4 hours 40 minutes

NeuBase Therapeutics, Inc. (NBSE)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.42100.0000 (0.00%)
At close: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 1.58M
Enterprise Value -5.66M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.17
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 0.19

Trading Information

Stock Price History

Beta (5Y Monthly) 0.96
52-Week Change 3-84.05%
S&P500 52-Week Change 322.64%
52 Week High 34.8000
52 Week Low 30.3900
50-Day Moving Average 30.6843
200-Day Moving Average 30.8016

Share Statistics

Avg Vol (3 month) 3239.86k
Avg Vol (10 day) 359.52k
Shares Outstanding 53.75M
Implied Shares Outstanding 63.75M
Float 83.3M
% Held by Insiders 113.38%
% Held by Institutions 112.69%
Shares Short (Mar 28, 2024) 4149.12k
Short Ratio (Mar 28, 2024) 40.6
Short % of Float (Mar 28, 2024) 44.12%
Short % of Shares Outstanding (Mar 28, 2024) 44.00%
Shares Short (prior month Feb 29, 2024) 4199.81k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Feb 04, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Jun 15, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Sept 30, 2022
Most Recent Quarter (mrq)Sept 30, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-43.03%
Return on Equity (ttm)-93.46%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -23.41M
Net Income Avi to Common (ttm)-24.59M
Diluted EPS (ttm)-18.6000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)12.57M
Total Cash Per Share (mrq)3.37
Total Debt (mrq)5.34M
Total Debt/Equity (mrq)58.39%
Current Ratio (mrq)7.40
Book Value Per Share (mrq)2.45

Cash Flow Statement

Operating Cash Flow (ttm)-24.69M
Levered Free Cash Flow (ttm)-15.18M